Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: World Neurosurg. 2018 Jun 27;117:e698–e704. doi: 10.1016/j.wneu.2018.06.114

Table 1.

Clinical characteristics, adjuvant therapy and overall outcome in each subject.

Animal # Age onset (yrs) Gender Primary sign MRI Diagnosis Path Diagnosis (if available) Pre CED Tumor Volume (cm3) on FLAIR Other Tumor Treatment Euthanasia Post-CED Survival (days)
1 7 F Seizures Left temporal lobe glioma Glioblastoma 10.7 None Yes 38
2 9 M Seizures Right fronto-temporal lobe glioma Anaplastic astrocytoma 14.3 TMZ Yes 82
3 9 F Seizures Left parieto-occipital lobe glioma None 2.6 None Yes 44
4 9 M Seizures Right temporal lobe glioma None 2.2 TMZ Yes 115
5 7 M Seizures Right thalamic glioma None 1.1 TMZ No Alive at 722 days
6 7 F Seizures Left fronto-parietal glioma None 4.3 None Yes 62
7 8 M Behavior change and seizures Right temporal lobe glioma Cystic meningioma 5.8 None Yes 13
8 8 M Seizures Right temporal lobe glioma None 4.9 None Yes 263
9 9 F Right hemiparesis and circling Right temporal glioma None 14.2 RT Yes 59
10 8 F Seizures, left hemiparesis, stupor, and disorientation Right parietal glioma High grade astrocytoma 12.6 None Died 1 day post-op 1